Tag Archives: antibiotic resistance

Persistent threats to U.S. children’s health the focus of #AHCJ19 session

Leave a reply
Tara Haelle

About Tara Haelle

Tara Haelle (@TaraHaelle) is AHCJ's medical studies core topic leader, guiding journalists through the jargon-filled shorthand of science and research and enabling them to translate the evidence into accurate information.

Ali H. Mokdad

While measles may be the hot topic in the news at the moment for children’s health, it’s far from the only concern. Even as the historical success of vaccines has reduced child mortality and morbidity from infectious disease, chronic disease, assault and injuries have increasingly become killers of U.S. children.

These were among the issues Ali H. Mokdad, Ph.D., a professor of global health at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington in Seattle, discussed during his session at Health Journalism 2019, “From measles to obesity: Key health trends affecting children and adolescents.” Continue reading →

Increasing infectious disease outbreaks highlight need for public health reporting

Leave a reply
Bara Vaida

About Bara Vaida

Bara Vaida (@barav) is AHCJ's core topic leader on infectious diseases. An independent journalist, she has written extensively about health policy and infectious diseases. Her work has appeared in outlets that include the National Journal, Agence France-Presse, Bloomberg News, McClatchy News Service, MSNBC, NPR, Politico and The Washington Post.

Deadly infectious disease outbreaks are occurring more often around the world.

Influenza virus circulated in the southern hemisphere and then spread to the U.S., killing about 80,000 people during this past flu season – the most in decades. Monkeypox, a rare disease outside of Africa, was found in three people in the United Kingdom for the first time. Ebola has broken out once again in Africa.

HuffPost’s Lauren Weber says this trend is the reason why infectious diseases is a mainstay of her beat as a public health reporter and why she has been able to cover the Ebola outbreak from Washington, D.C. Continue reading →

Tell stories about lab rats on the radio

Leave a reply
Bara Vaida

About Bara Vaida

Bara Vaida (@barav) is AHCJ's core topic leader on infectious diseases. An independent journalist, she has written extensively about health policy and infectious diseases. Her work has appeared in outlets that include the National Journal, Agence France-Presse, Bloomberg News, McClatchy News Service, MSNBC, NPR, Politico and The Washington Post.

A cup of coffee with a former journalist colleague led Rhode Island radio reporter Lynn Arditi down the path of reporting on “superbugs,” the term for antibiotic-resistant bacteria.

Arditi’s former colleague was working for LifeSpan, a large Rhode Island health system, and pitched her the story of a study authored by one of its lead researchers and infectious diseases specialists. The study was about the discovery of a set of compounds that could become a new class of antibiotics to treat drug-resistant bacteria. Continue reading →

In race between bugs and drugs, the bugs are pulling ahead

Leave a reply
Victoria Colliver

About Victoria Colliver

Victoria Colliver (@vcolliver) is Politico Pro’s California-based health care reporter. Previously, she wrote about the health industry and medicine for the San Francisco Chronicle since 2001. Prior to the Chronicle, she worked for the San Francisco Examiner and the Oakland Tribune.

Photo: Francisco Bengoa via Flickr

PHOENIX – To picture a future in which antibiotics no longer work, all we have to do is look at the past – at the United States before the 1940s when simple infections accounted for a third of all deaths.

“When an antibiotic resistance develops anywhere, it’s a threat to people everywhere,” said Elizabeth Jungman, director of The Pew Charitable Trusts’ public health programs, speaking at a panel on Friday at Health Journalism 2018 that painted a chilling but prescient view of what could happen if and when antibiotics stop working, and we don’t have enough new drugs in the pipeline. “We know what a post-antibiotic world could look like because we lived in a pre-antibiotic world.” Continue reading →

Putting a human face on new antimicrobial research

Leave a reply
Bara Vaida

About Bara Vaida

Bara Vaida (@barav) is AHCJ's core topic leader on infectious diseases. An independent journalist, she has written extensively about health policy and infectious diseases. Her work has appeared in outlets that include the National Journal, Agence France-Presse, Bloomberg News, McClatchy News Service, MSNBC, NPR, Politico and The Washington Post.

Photo: CDC/Courtesy of Larry Stauffer, Oregon State Public Health LaboratoryA positive result of a phage test showing diminished growth (arrowhead) where a gamma phage suspension had been applied.

A desire to put a human face to antibiotic resistance led reporter Chris Dall to dig into the relatively unknown world of viral research aimed at killing superbugs.

Dall began investigating bacteriophages, which are viruses that kill bacteria, when he was assigned a story to write about a study that appeared in the scientific journal, Antimicrobial Agents and Chemotherapy in August 2017. The report dryly described a method of using viruses to save a 68-year-old man, who was dying from an antibiotic-resistant infection. Continue reading →

Antibiotic resistance highlighted at World Conference of Science Journalists

Leave a reply
Tara Haelle

About Tara Haelle

Tara Haelle (@TaraHaelle) is AHCJ's medical studies core topic leader, guiding journalists through the jargon-filled shorthand of science and research and enabling them to translate the evidence into accurate information.

U.S. Centers for Disease Control and Prevention

Alexander Fleming developed penicillin, the first antibiotic, in 1928. In less than a century, scientists have developed more than 130 other antibiotics — saving millions of lives, making surgery safer than ever, transforming medicine … and creating the huge new problem of antibiotic resistance that threatens to toss us back into the pre-antibiotic era.

Take gonorrhea for just one example: humans have gone from having no way to treat the disease in the 1920s to having effective antibiotics against it to now, when the “bacteria has developed resistance to nearly every drug used for treatment,” according to the CDC. Continue reading →